title: Synthesis of diacylglycerol de novo is responsible for permanent activation and down-regulation of protein kinase C in transformed cells.
abstract: We measured the synthesis of diacylglycerol de novo in normal NIH/3T3 fibroblasts and in cells transformed by ras, src, sis and abl oncogenes. Analysis of the incorporation of glucose-derived 14C into diacylglycerol indicated that neosynthesis of diacylglycerol was constitutively active in the transformed cell lines. Elevated levels of diacylglycerol and persistent activation/down-regulation of protein kinase C reduced the binding of phorbol dibutyrate to transformed cells. This phenomenon could be reversed by blocking the glycolytic pathway, thus indicating that neosynthesized diacylglycerol was responsible for persistent activation and down-regulation of protein kinase C. In transformed cells, protein kinase C activity could not be stimulated by the addition of diolein; however, inhibition of glycolysis restored the ability of transformed cells to respond to diolein. Taken together these data indicate that constitutive synthesis of diacylglycerol de novo is responsible for activation and down-regulation of protein kinase C in transformed cells, and it may play a role in altered mitogenic signalling.
authors.affiliation: Laboratory of Molecular Biology, University of Firenze, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Chiarugi
authors.forename: P
authors.initials: P
authors.lastname: Bruni
authors.forename: F
authors.initials: F
authors.lastname: Pasquali
authors.forename: L
authors.initials: L
authors.lastname: Magnelli
authors.forename: G
authors.initials: G
authors.lastname: Basi
authors.forename: M
authors.initials: M
authors.lastname: Ruggiero
authors.forename: M
authors.initials: M
authors.lastname: Farnararo
mesh_terms: D000818:Animals; D029742:Caenorhabditis elegans Proteins; D002250:Carbon Radioisotopes; D002352:Carrier Proteins; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D003600:Cytosol / Q000201:enzymology; D003847:Deoxyglucose / Q000494:pharmacology; D004075:Diglycerides / Q000096:biosynthesis* / Q000494:pharmacology / Q000502:physiology; D011905:Genes, ras; D005947:Glucose / Q000378:metabolism; D005989:Glycerides / Q000096:biosynthesis*; D006019:Glycolysis / Q000187:drug effects; D007700:Kinetics; D051379:Mice; D008815:Mice, Inbred Strains; D009857:Oncogenes; D015240:Phorbol 12,13-Dibutyrate / Q000378:metabolism; D011493:Protein Kinase C / Q000378:metabolism*; D011955:Receptors, Drug / Q000378:metabolism
chemical_list: D029742:Caenorhabditis elegans Proteins; D002250:Carbon Radioisotopes; D002352:Carrier Proteins; D004075:Diglycerides; D005989:Glycerides; D011955:Receptors, Drug; C083141:phorbol ester binding protein; C027776:phorbol ester receptor; D015240:Phorbol 12,13-Dibutyrate; D003847:Deoxyglucose; D011493:Protein Kinase C; D005947:Glucose; C013965:diolein